← Open Payments lookup

ANASTASIA AMIRAMOVA: Open Payments

NPI 1982327987 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,825 in 110 payments from 15 companies in 2025. Trend: 2023 $2,071 · 2024 $4,056 · 2025 $2,825

Food & beverage: $2,725Education: $100
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$836
ABBVIE INC.19$413
E.R. Squibb & Sons, L.L.C.20$319
Axsome Therapeutics, Inc.13$313
HARMONY BIOSCIENCES LLC6$238
Luye Pharma (USA) Ltd.4$198
Alkermes, Inc.5$175
Supernus Pharmaceuticals, Inc.1$125
Teva Pharmaceuticals USA, Inc.2$41
Collegium Pharmaceutical, Inc.2$40

Products named: CAPLYTA, VRAYLAR, COBENFY, Auvelity, ERZOFRI EXTENDED-RELEASE, WAKIX, Qelbree, LYBALVI.

Industry payments across MO — which companies pay providers there.